Background: We tested the primary hypothesis that corticosteroid administration after etomidate exposure reduces a composite of in-hospital mortality and cardiovascular morbidity after non-cardiac surgery. Methods: We evaluated ASA physical status III and IV patients who had non-cardiac surgery with general anaesthesia at the Cleveland Clinic. Amongst 4275 patients in whom anaesthesia was induced with etomidate, 804 were also given steroid intraoperatively, mostly dexamethasone at a median dose of 6 mg. We successfully matched 582 steroid patients with 1023 non-steroid patients. The matched groups were compared on composite of in-hospital mortality and cardiovascular morbidity using a generalized-estimating-equation model. Secondly, the matched groups were compared on length of hospital stay using a Cox proportional hazard model, and were descriptively compared on intraoperative blood pressures using a standardized difference. Results: There was no significant association between intraoperative steroid administration after anaesthetic induction with etomidate and the composite of in-hospital mortality or cardiovascular morbidity; the estimated common odds ratio across the two components of the composite was 0.86 [95% confidence interval (CI): 0.64, 1.16] for steroid vs nonsteroid, P¼0.33. The duration of postoperative hospitalisation was significantly shorter amongst steroid patients [median (Q1, Q3): 6 (3, 10) days] than non-steroid patients [7 (4, 11) days], with an estimated hazard ratio of 0.89 (0.80, 0.98) for steroid vs non-steroid, P¼0.01. Intraoperative blood pressures were similar in steroid and non-steroid patients. Conclusions: Steroid administration after induction of anaesthesia with etomidate did not reduce mortality or cardiovascular morbidity.
Etomidate, at typical anaesthetic induction doses, causes adrenal suppression 1 that lasts at least 6 h in healthy patients 2 and >24 h in those who are critically ill. 3, 4 Etomidate thus seems likely to exacerbate the already substantial risk of adrenal insufficiency in high-risk surgical patients. Consistent with this theory, we recently reported that there is an association between etomidate and adverse outcomes in the ASA physical status III and IV adults having non-cardiac surgery. Specifically, patients given etomidate for anaesthetic induction had significantly greater odds of in-hospital postoperative mortality [odds ratio (OR), 2.5; 98% confidence interval (CI), 1.8e3.3] and significantly greater odds of having cardiovascular morbidity (OR, 1.5; 98% CI, 1.2e2.0). 5 Adrenal suppression seems a likely explanation for worse outcomes in patients given etomidate. But, it remains unclear whether steroid administration after etomidate exposure blunts the putative harmful effects of etomidate. In sepsis 6 and septic shock, 7e9 most studies do not report a mortality benefit from steroid supplementation, 6e9 although one study showed shorter mechanical ventilation times and a lower requirement for vasopressors. 8 In predominantly trauma populations, a study showed decreased vasopressor requirement, 10 whilst the other showed decreased mechanical ventilation time, decreased incidence of hospital-acquired pneumonia, and shorter intensive-care-unit (ICU) stays. 11 We thus tested the primary hypotheses that amongst ASA physical status III and IV adults having non-cardiac surgery under general anaesthesia induced with etomidate, intraoperative steroid administration reduces a composite of inhospital mortality and major in-hospital cardiovascular morbidity.
Methods
With institutional review board approval and waived informed consent, we queried the Perioperative Health Documentation System Registry of the Cleveland Clinic between May 2005 and September 2015. The Cleveland Clinic's Perioperative Health Documentation System contains all patients who had noncardiac surgery at the Cleveland Clinic Main Campus since May 2005. It integrates preoperative variables (patient and baseline characteristics), intraoperative variables from our anaesthesia record-keeping system (Talis Clinical, Inc., Streetsboro, Ohio, USA), and postoperative outcomes (by linking to Cleveland Clinic billing and other systems).
The study population consisted of ASA physical status III and IV adults having non-cardiac inpatient surgery, in which general anaesthesia was induced with etomidate, with or without a combined regional anaesthesia. Anaesthesia was maintained with a volatile anaesthetic, supplemented per clinical preference with opioids and neuromuscular blocking agents. Patients who used systemic steroids before operation were excluded.
We matched each patient who received intraoperative steroid (steroid patients) to a maximum of two patients who did not (non-steroid patients), using propensity-score matching 12 to control for observed potential confounding. First, we estimated the probability of receiving intraoperative steroid (i.e. propensity score) for each patient using logistic regression with steroid (vs non-steroid) as the outcome, and all prespecified patient and baseline characteristics as independent variables. Matching was then implemented using a greedy algorithm (SAS macro: gmatch, SAS Institue Inc., Cary, North Carolina, USA 14 based on all baseline characteristics and outcomes was implemented for BMI, which was missing for 7.7% of all patients. Assessment of balance on the covariates used for the propensity-score matching was performed using absolute standardized differences (ASD, i.e. the absolute difference in means or proportions divided by the pooled standard deviation). Imbalance was defined as an ASD greater than 0.1; any such covariates were included in the models so as to reduce potential confounding when comparing steroid and nonsteroid patients on outcomes. All of the analyses were based on this subset of matched patients.
Primary outcomes
The matched steroid and non-steroid patients were compared on the collapsed composite of in-hospital mortality and cardiovascular morbidity (Table 1) . We assessed the 'common effect' of intraoperative steroid across the two individual components of the composite using a generalized-estimatingequation (GEE) model with an unstructured covariance matrix. 15 We reported the individual ORs from the distinct-effect GEE model regardless of the significance of the heterogeneity 
Secondary outcomes
Within the propensity-score-matched subset of steroid and non-steroid patients, we also assessed the association between intraoperative steroid administration and length of hospital stay. We built a Cox proportional hazard model 16 with 'discharged alive' as the outcome event. Patients who died in a hospital were considered as never having the event and were assigned a censoring time 1 day greater than the observed longest duration of the hospitalisation amongst those discharged alive. Additionally, as adrenal insufficiency has been associated with hypotension, to see if corticosteroid supplementation after etomidate is associated with more stable intraoperative haemodynamics (i.e. less hypotension) in comparison to those who were not treated with corticosteroid, we showed the within-patient average and minimum of systolic and diastolic blood pressure in each intraoperative period (i.e. from induction to intubation, intubation to incision, incision to closing, closing to emergence, and emergence to end of case). Differences between the matched steroid and non-steroid patients were estimated using a standardized difference.
We used all patients who met the study inclusion/exclusion criteria. With 1605 matched patients, we had about 90% power at the 0.05 significance level to detect a commoneffect OR of 0.6 or stronger across the two components of the composite of in-hospital mortality and cardiovascular morbidity for steroid patients vs non-steroid patients, assuming incidences of 5% for in-hospital mortality and 10% for cardiovascular morbidity, and assuming a compound symmetric correlation structure with a between-outcome correlation of 0.05. The power calculation was based on 1000 simulations using an SAS macro developed for designs with multiple binary correlated end points ('multibinpow'). 17 The SAS program uses simulations to compute and display comparative power of several parallel-group multivariate tests for treatment effect on a vector of binary events. 18 SAS software, version 9.4 (SAS Institute, Cary, NC, USA) was used for all analyses.
Results
We identified 4275 patients who met the inclusion and exclusion criteria, including 804 steroid patients (19%) and 3471 non-steroid patients (81%). Amongst the 804 steroid patients, 57% received dexamethasone, 26% received hydrocortisone, 16% received methylprednisolone, and 1% received other types. Based on patient and baseline characteristics, we successfully matched 582 steroid patients (72% of 804 steroid patients) with 1023 non-steroid patients. Specifically, the steroid and non-steroid patients were exactly matched on the type of surgery, and were much better balanced on other covariates as a result of propensity-score matching (Table 2 ; Fig. A1 ). Only the history of carotid disease and year of surgery were slightly imbalanced (ASD >0.1) after the propensity-score matching, which were adjusted in all analyses comparing steroid and non-steroid patients. 
Primary outcomes
Within the matched subset of patients, no significant association was found between the intraoperative steroid administration and the composite of in-hospital mortality or cardiovascular morbidity; the estimated common effect across the two components of the composite was 0.86 (0.64, 1.16) for steroid vs non-steroid (P¼0.33; Table 3 ). The incidence of inhospital mortality was 4.6% for both steroid and non-steroid patients, with an estimated OR of 1.01 (97.5% CI: 0.58, 1.76) for steroid vs non-steroid; P¼0.97. Likewise, the incidence of having postoperative cardiovascular morbidity was 9.8% for steroid patients and 12.1% for non-steroid patients, with an estimated OR of 0.79 (97.5% CI: 0.54, 1.15) for steroid vs nonsteroid; P¼0.16.
Secondary outcomes
Steroid administration after the anaesthetic induction with etomidate was significantly associated with shorter length of hospital stay (log-rank test; P¼0.01; Fig. A2 ). The estimated median durations of postoperative hospitalisation from the KaplaneMeier curve were 6 (Q1, Q3: 3, 10) days for steroid patients and 7 (4, 11) days for non-steroid patients. The estimated hazard ratio of staying in the hospital after surgery was 0.89 (95% CI: 0.80, 0.98) for steroid vs non-steroid, after adjusting for history of carotid disease and year of surgery (P¼0.01). Discharges for patients who died in the hospital were considered as non-events and censored at the longest observed length of stay.
The within-patient average and minimum of systolic and diastolic blood pressure during any intraoperative period were similar in the steroid and non-steroid patients, and is summarized by standardized differences in Table 4 .
Discussion
Intraoperative administration of steroids was not associated with decreased in-hospital mortality and cardiovascular morbidity in ASA physical status III and IV inpatients having non-cardiac surgery in which general anaesthesia was induced with etomidate (our primary outcome). The median length of hospital stay was shorter in patients given steroids (6 days) than for non-steroid patients (7 days; P¼0.01), but this secondary outcome was probably of marginal clinical importance.
In a predominantly elective surgical population, a single dose of etomidate suppresses serum cortisol concentration for 6e24 h, 2, 19 and the studies that used the cosyntropin stimulation test have shown that relative adrenal insufficiency caused by etomidate lasts up to 24 h. 20, 21 Whether etomidate-induced (7) 283 (8) 42 (7) 80 (8) 2006 88 (11) 440 (13) 68 (12) 139 (14) 2007 87 (11) 402 (12) 67 (12) 107 (10) 2008 90 (11) 447 (13) 67 (12) 130 (13) 2009 84 (10) 489 (14) 63 (11) 135 (13) 2010 99 (12) 511 (15) 68 (12) 132 (13) 2011 61 (8) 267 (8) 45 (8) 81 (8) 2012 46 (6) 174 (5) 33 (6) 50 (5) 2013 70 (9) 172 (5) 51 (9) 64 (6) 2014 68 (8) 171 (5) 45 (8) 65 (6) 2015 57 (7) 115 (3) 33 (6) (10) 320 (21) 30 (13) 58 (13) Aortic resection, replacement, or anastomosis 25 (7) 308 (20) 25 (11) (5) 23 (10) 43 (10) adrenal suppression translates into adverse clinical outcomes is controversial. In cardiac surgical patients, Iribarren and colleagues 22 showed that the patients who received etomidate required a higher dose of vasopressors during the postoperative period than those who received other induction agents, whilst other studies found no difference in vasopressor requirement 20 and outcomes, including mechanical ventilation time and length of ICU and hospital stay, between etomidate and other induction agents. 21, 23, 24 In non-cardiac surgery, one study demonstrated no differences in intraoperative haemodynamic parameters, vasopressor requirement, 19 and length of hospital stay between etomidate and propofol, although our previous work showed an increased incidence of postoperative cardiovascular morbidities. 5 Information regarding the effect of corticosteroid supplementation after etomidate exposure in an elective surgical population is scarce. By using a 3 day tapering hydrocortisone supplementation regimen, starting at 300 mg daily on the day of surgery followed by 200 mg daily on Day 1 and 100 mg daily on Day 2, Basciani and colleagues 21 showed no benefit of corticosteroid supplementation after etomidate exposure with regard to vasopressor requirement, mechanical ventilation time, length of ICU stay, and mortality. The patients in the current study were given a single relatively low intraoperative dose of dexamethasone, hydrocortisone, or methylprednisolone. It is thus likely that etomidate-induced adrenal suppression, which can exceed 24 h, 3 outlasted the steroid effect in our patients, and the putative benefit of corticosteroid supplementation might not manifest clinically in the current study.
In our previous study, also based on an analysis of the Cleveland Clinic perioperative registry, 5 we observed a marginally prolonged hospitalisation in patients given etomidate vs propofol for anaesthetic induction (median: 7 days vs 6 days). In the current analysis, which was restricted to patients given etomidate, the median length of hospital stay was 6 days in patients given steroid and 7 days in those who were not (P¼0.01). Whilst it is tempting to attribute shortened hospitalisation in patients given steroids to 'reversal' of etomidateinduced adrenal suppression, we note that there may be beneficial effects of steroid unrelated to adrenal function, including reduced postoperative pain 25 and fatigue.
26
Steroid administration was not randomly assigned; instead, it was provided at the discretion of attending anaesthesiologists. To reduce selection bias attributable to observed covariates, we matched the patients exactly on type of surgery, and then used propensity-score matching to develop comparable comparison groups. The groups were in fact well balanced on observed factors potentially influencing outcomes of interest. But, there possibly remains a degree of selection bias and confounding related to factors that were unavailable in our electronic records, and yet-to-be-identified confounding factors.
For example, we were unable to adjust for the fact that various surgical approaches are characterized by the same surgical billing codes. Because data were not available electronically, we were also unable to account for a number of factors that potentially affect adrenal function, such as postoperative steroid use, and preoperative use of medications that inhibit cortisol biosynthesis (i.e. ketoconazole, metyrapone, and suramin) or those that increase steroid metabolism (i.e. carbamazepine, phenobarbital, phenytoin, rifampicin, and mitotane). Further, although we showed similar intraoperative haemodynamic parameters between those who received and did not receive steroid, as the information regarding intraoperative vasopressors and inotrope doses was not available, we cannot conclude that both groups had similar haemodynamic stability. As with all observational studies, we report statistical associations, which may or may not indicate causal relationships between steroid In summary, in our analysis of ASA physical status III and IV non-cardiac surgical inpatients that were given etomidate for induction of general anaesthesia, intraoperative steroid administration (mostly at doses suitable for nausea and vomiting prophylaxis) was not associated with decreased odds of in-hospital mortality or cardiovascular morbidity. Steroid administration was associated with a slightly shorter duration of hospitalisation, a finding that is probably of only marginal clinical importance.
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Appendix. Fig. A1 . Plot of absolute standardized difference of co-variables used to estimate the propensity score before and after the propensity-score matching. COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; HPA, hypothalamicepituitaryeadrenal. Fig. A2 . KaplaneMeier estimates of probability of being discharged from hospital (lines) and associated 95% equal-precision confidence bands (shaded regions) for propensity-score-matched steroid (N¼582) and non-steroid patients (N¼1023). Patients who died in the hospital were considered as not being discharged and censored at the longest observed length of stay; thus, the curves did not reach 100% at the end. These univariable KaplaneMeier estimates were statistically different between steroid and non-steroid patients (log-rank test; P¼0.01).
